Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03535883 · ClinicalTrials.gov registry record
The Safety of Thoracentesis, Tunneled Pleural Catheter, and Chest Tubes in Patients Taking Novel Oral Anti-Coagulants
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 590
- Enrollment target
NCT03535883 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 590 participants.
The verdict
NCT03535883 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 590 participants
- Enrollment target
Study Summary
To assess risks of bleeding in those individuals receiving Novel Oral Anti-Coagulant (NOAC) medications, admitted to the hospital and require thoracentesis, chest tube or tunneled pleural catheter placement.
Interventions
- DRUG Novel Oral Anti-Coagulants
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 590 participants |
| Start Date | 2017-10-30 |
| Est. Completion | 2020-01-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03535883
The ClinicalTrials.gov registry entry for NCT03535883 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 590 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Novel Oral Anti-Coagulants is the first listed.
NCT03535883 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03535883 about?
NCT03535883 is a clinical study titled "The Safety of Thoracentesis, Tunneled Pleural Catheter, and Chest Tubes in Patients Taking Novel Oral Anti-Coagulants". To assess risks of bleeding in those individuals receiving Novel Oral Anti-Coagulant (NOAC) medications, admitted to the hospital and require thoracentesis, chest tube or tunneled pleural catheter placement.
What is the current status of trial NCT03535883?
This trial is currently completed. The enrollment target is 590 participants. The study started on 2017-10-30. Estimated completion is 2020-01-01.
What interventions are being tested in trial NCT03535883?
The interventions under investigation include: Novel Oral Anti-Coagulants (DRUG).
Who is sponsoring clinical trial NCT03535883?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.